Compare EC & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EC | IQV |
|---|---|---|
| Founded | 1948 | 1982 |
| Country | Colombia | United States |
| Employees | N/A | 93000 |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3B | 34.6B |
| IPO Year | 2008 | 2013 |
| Metric | EC | IQV |
|---|---|---|
| Price | $15.52 | $206.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $227.13 |
| AVG Volume (30 Days) | ★ 3.2M | 1.5M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.80% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 1.61 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.89 |
| P/E Ratio | $170.91 | ★ $129.93 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $8.27 | $154.50 |
| 52 Week High | $17.75 | $247.05 |
| Indicator | EC | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 67.75 |
| Support Level | $15.05 | $206.72 |
| Resistance Level | $16.63 | $209.48 |
| Average True Range (ATR) | 0.65 | 6.63 |
| MACD | 0.00 | 1.95 |
| Stochastic Oscillator | 40.00 | 92.08 |
Ecopetrol SA is engaged in commercial and industrial activities related to the exploration, exploitation, refining, transportation, storage, distribution, and marketing of hydrocarbons, their derivatives, and products, as well as the electric power transmission services, design, development, construction, operation, and maintenance of road and energy infrastructure projects and the provision of information technology and telecommunications services. The operations of the company are performed through four business segments: Exploration and Production, Transport and Logistics, Refining and Petrochemical, and Electric Power Transmission and Toll Roads Concessions. The majority of the company's revenue is generated from the Exploration and Production segment.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.